389 related articles for article (PubMed ID: 28414772)
21. Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.
Kang B; Okwieka P; Schöttler S; Winzen S; Langhanki J; Mohr K; Opatz T; Mailänder V; Landfester K; Wurm FR
Angew Chem Int Ed Engl; 2015 Jun; 54(25):7436-40. PubMed ID: 25940402
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticle-protein complexes mimicking corona formation in ocular environment.
Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH
Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757
[TBL] [Abstract][Full Text] [Related]
23. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
[TBL] [Abstract][Full Text] [Related]
24. Characterizing the protein corona of sub-10 nm nanoparticles.
Glancy D; Zhang Y; Wu JLY; Ouyang B; Ohta S; Chan WCW
J Control Release; 2019 Jun; 304():102-110. PubMed ID: 31004667
[TBL] [Abstract][Full Text] [Related]
25. Analysis of nanoparticle biomolecule complexes.
Gunnarsson SB; Bernfur K; Mikkelsen A; Cedervall T
Nanoscale; 2018 Mar; 10(9):4246-4257. PubMed ID: 29436548
[TBL] [Abstract][Full Text] [Related]
26. Surface roughness influences the protein corona formation of glycosylated nanoparticles and alter their cellular uptake.
Piloni A; Wong CK; Chen F; Lord M; Walther A; Stenzel MH
Nanoscale; 2019 Dec; 11(48):23259-23267. PubMed ID: 31782458
[TBL] [Abstract][Full Text] [Related]
27. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
[TBL] [Abstract][Full Text] [Related]
28. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles.
Hadjidemetriou M; Al-Ahmady Z; Kostarelos K
Nanoscale; 2016 Apr; 8(13):6948-57. PubMed ID: 26961355
[TBL] [Abstract][Full Text] [Related]
29. Single particle extinction and scattering optical method unveils in real time the influence of the blood components on polymeric nanoparticles.
Sanvito T; Bigini P; Cavanna MV; Fiordaliso F; Violatto MB; Talamini L; Salmona M; Milani P; Potenza MAC
Nanomedicine; 2017 Nov; 13(8):2597-2603. PubMed ID: 28756089
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticles Penetrate into the Multicellular Spheroid-on-Chip: Effect of Surface Charge, Protein Corona, and Exterior Flow.
Huang K; Boerhan R; Liu C; Jiang G
Mol Pharm; 2017 Dec; 14(12):4618-4627. PubMed ID: 29096441
[TBL] [Abstract][Full Text] [Related]
31. Clusterin in the protein corona plays a key role in the stealth effect of nanoparticles against phagocytes.
Aoyama M; Hata K; Higashisaka K; Nagano K; Yoshioka Y; Tsutsumi Y
Biochem Biophys Res Commun; 2016 Nov; 480(4):690-695. PubMed ID: 27983983
[TBL] [Abstract][Full Text] [Related]
32. Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns.
Lai W; Wang Q; Li L; Hu Z; Chen J; Fang Q
Colloids Surf B Biointerfaces; 2017 Apr; 152():317-325. PubMed ID: 28131092
[TBL] [Abstract][Full Text] [Related]
33. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
[TBL] [Abstract][Full Text] [Related]
34. Temperature, concentration, and surface modification influence the cellular uptake and the protein corona of polystyrene nanoparticles.
Oberländer J; Champanhac C; da Costa Marques R; Landfester K; Mailänder V
Acta Biomater; 2022 Aug; 148():271-278. PubMed ID: 35732233
[TBL] [Abstract][Full Text] [Related]
35. Interplay between nanomedicine and protein corona.
Yang M; Wu E; Tang W; Qian J; Zhan C
J Mater Chem B; 2021 Sep; 9(34):6713-6727. PubMed ID: 34328485
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the influence of protein corona composition on gold nanoparticle bioactivity using machine learning approaches.
Papa E; Doucet JP; Sangion A; Doucet-Panaye A
SAR QSAR Environ Res; 2016 Jul; 27(7):521-38. PubMed ID: 27329717
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of the Enzymatic Degradation of Protein Corona and Evaluating the Accompanying Cytotoxicity of Nanoparticles.
Ma Z; Bai J; Jiang X
ACS Appl Mater Interfaces; 2015 Aug; 7(32):17614-22. PubMed ID: 26200209
[TBL] [Abstract][Full Text] [Related]
38. Serum heat inactivation affects protein corona composition and nanoparticle uptake.
Lesniak A; Campbell A; Monopoli MP; Lynch I; Salvati A; Dawson KA
Biomaterials; 2010 Dec; 31(36):9511-8. PubMed ID: 21059466
[TBL] [Abstract][Full Text] [Related]
39. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
40. In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape.
García-Álvarez R; Hadjidemetriou M; Sánchez-Iglesias A; Liz-Marzán LM; Kostarelos K
Nanoscale; 2018 Jan; 10(3):1256-1264. PubMed ID: 29292433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
